~~<i id='F84491C009'><strike id='F84491C009'><tt id='F84491C009'><pre id='F84491C009'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

leisure time

author：fashion 2025-09-30 15:23:08 - browse：62

Photo illustration of a single pill on a large white field – opinion coverage from STAT — Adobe

This time last year, members of Congress were working around the clock to draft and pass the Inflation Reduction Act.

One of their goals was to address government spending on health care. But they specifically didn’t want to discourage research into rare disease treatments, so they exempted some of these so-called orphan drugs from the law.

Unfortunately, the exemptions aren’t working as intended. Unless Congress acts, the IRA threatens to unravel one of America’s greatest medical and public policy success stories: the explosion of new treatments for patients living with rare diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： FDA advisers back CAR

entertainment

Wikipedia

hotspot

entertainment

focus

entertainment

Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa

WSS

Why sickle cell disease is getting the first CRISPR treatment

Ebola: Gilead Sciences antiviral shows promise as new treatment

FDA approves world's first CRISPR

AI models in health care face new federal disclosure requirements

Readout Newsletter: CAR

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

explore

leisure time

entertainment

Hollywood unions extend contract negotiations for actors

Radiology is caught between AI's potential and concern for patients

As demand for Covid shots wanes, Moderna seeks its next success

Pfizer plans to depart BIO

Continuity nursing helped my family in our darkest PICU moments

HHS secretary Becerra pressed on Change HealthCare cyberattack

George Santos makes 1st court appearance after pleading not guilty to 13 counts

CMS should re

Jerome Adams on the need for new antivirals for Covid

As AI in medicine takes off, can 'human in the loop' prevent harm?

Wikipedia

Radiology is caught between AI's potential and concern for patients

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

AI models in health care face new federal disclosure requirements

AI models in health care face new federal disclosure requirements

Why depression after traumatic brain injury is distinct

The woman behind the Dana Farber

hotspot

entertainment

focus

entertainment